Medicine for treating pneumoconiosis

A drug and pneumoconiosis technology, applied in the field of drugs for the treatment of pneumoconiosis, can solve the problems of unsatisfactory treatment effect, unsuitable for large-scale use, lack of treatment for pneumoconiosis, etc., achieve clinical adverse reactions are not obvious, improve the body's immunity and resistance Oxidative capacity, the effect of clinical application safety

Inactive Publication Date: 2011-05-18
许海涛
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the past, the treatment of pneumoconiosis mostly used a single species, such as zinc gluconate, quinoquinone phosphate, tirole hydrochloride, yellow root and other drugs. These drugs are not effective when used alone, and the overall therapeutic effect is not satisfactory; Some pure Chinese medicine prescriptions for the treatment of pneumoconiosis, some are palliative, not the root cause, some use expensive ingredients, some are discontinued due to inaccurate curative effect during the application process, and some are more cumbersome and not suitable for wide-scale use
In short, there has been a lack of an effective combined prescription for the treatment of pneumoconiosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] A medicine for treating pneumoconiosis. The components are calculated in parts by weight, and the ratio is: 40 parts of zinc gluconate, 0.2 parts of quinopiperphosphate, 1.5 parts of terool hydrochloride, 9 parts of yellow root and 4 parts of licorice.

[0033] The raw materials and medicines of the above components are mixed evenly, and they are jointly pulverized into a coarse powder, which is passed through a 50-100 mesh sieve, and the sieved crude drug powder is made into tablets, and every 30 tablets are packed in a bottle as a finished product.

[0034] In the above prescription, each serving is 1g.

Embodiment 2

[0036] A medicine for treating pneumoconiosis. The components are calculated in parts by weight, and the proportion is: 50 parts of zinc gluconate, 0.15 parts of quinoquinone phosphate, 1 part of terool hydrochloride, 8 parts of yellow root and 9 parts of licorice.

[0037] The raw materials and medicines of the above components are mixed evenly, and they are jointly pulverized into a coarse powder, which is passed through a 50-100 mesh sieve, and the sieved crude drug powder is made into tablets, and every 30 tablets are packed in a bottle as a finished product.

[0038] In the above prescription, each serving is 5g.

Embodiment 3

[0040] A medicine for treating pneumoconiosis. The components are calculated in parts by weight, and the ratio is: 60 parts of zinc gluconate, 0.1 part of quinoquinone phosphate, 3 parts of terool hydrochloride, 5 parts of yellow root and 7 parts of licorice.

[0041] The raw materials and medicines of the above components are mixed evenly, and they are jointly pulverized into a coarse powder, which is passed through a 50-100 mesh sieve, and the sieved crude drug powder is made into tablets, and every 30 tablets are packed in a bottle as a finished product.

[0042] In the above prescription, each serving is 5g.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicine for treating pneumoconiosis, which has simple preparation method and low cost. Zinc gluconate, piperaquine phosphate, tilorone dihydrochloride and traditional Chinese medicinal herbs fourstamen prismatomeris root and licorice are used as main ingredients of the medicine. The medicine is orally administered in the form of tablets, so as to be convenient in carrying and administration for patients. Meanwhile, the medicine has good curative effect on pneumoconiosis, and is suitable for pneumoconiosis patients at various ages and stages.

Description

technical field [0001] The invention relates to a medicine, in particular to a medicine for treating pneumoconiosis. Background technique [0002] Pneumoconiosis refers to a lung disease characterized by fibrous tissue hyperplasia caused by long-term inhalation of large amounts of respirable dust by workers during occupational activities. The basic lesions of pneumoconiosis are the formation of silicon nodules and extensive fibrosis of the pulmonary interstitium. The formation of silicon nodules due to lung tissue fibrosis is irreversible. If you get this disease, it will gradually develop and eventually lead to death due to the loss of respiratory function of the lungs. [0003] According to the figures released by the Ministry of Health, since the 1950s, as of 2005, a total of 607,570 cases of pneumoconiosis have been reported in my country, which is equivalent to the sum of pneumoconiosis patients in other countries in the world, and more than 140,000 people have died. Mo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/74A61P11/00A61K31/15A61K31/191A61K31/497
Inventor 许海涛朱玉美刘建永贺玉静李郭东周生明王瑞海
Owner 许海涛
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap